Severe West Nile virus and Sars-CoV-2 infections in a patient with thymoma and anti-type I IFN antibodies.
Federica BarzaghiCamilla ViscontiGiovanni Battista PipitoneSimone BondesanGiulia MolliStefania GiannelliClaudia SartiranaVito LampasonaElena BazzigaluppiCristina BrigattiAdrian GervaisPaul BastardChiara Tassan DinChiara MolinariLorenzo PiemontiJean-Laurent CasanovaPaola CarreraGiorgio CasariAlessandro AiutiPublished in: The Journal of infectious diseases (2024)
The current study aimed to investigate determinants of severity in a previously healthy patient who experienced two life-threatening infections, from West Nile Virus and SARS-CoV2. During COVID19 hospitalization he was diagnosed with a thymoma, retrospectively identified as already present at the time of WNV infection. Heterozygosity for p.Pro554Ser in the TLR3 gene, which increases susceptibility to severe COVID-19, and homozygosity for CCR5 c.554_585del, associated to severe WNV infection, were found. Neutralizing anti-IFN-α and anti-IFN-ω auto-antibodies were detected, likely induced by the underlying thymoma and increasing susceptibility to both severe COVID-19 pneumonia and West Nile encephalitis.